STI571 (imatinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STI571 (imatinib), covering 2014-09-15 to 2014-09-15. Get the full timeline:
Most recent: Clinical Trial Update: Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571 [Phase 1, Phase 2]